Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
Pract Neurol
.
2015 Aug;15(4):273-9.
doi: 10.1136/practneurol-2015-001139.
Epub 2015 Jun 22.
Authors
Neil Scolding
1
,
David Barnes
2
,
Sarah Cader
3
,
Jeremy Chataway
4
,
Abhijit Chaudhuri
5
,
Alasdair Coles
6
,
Gavin Giovannoni
7
,
David Miller
4
,
Waqar Rashid
8
,
Klaus Schmierer
9
,
Abdullah Shehu
10
,
Eli Silber
11
,
Carolyn Young
12
,
John Zajicek
13
Affiliations
1
Bristol Institute of Clinical Neurosciences, Learning and Research Building, Southmead Hospital, Bristol, UK.
2
Department of Neurology, St George's University Hospital, London, UK.
3
Department of Neurology, Basingstoke Hospital, Basingstoke, UK.
4
Department of Neurology, National Hospital for Neurology and Neurosurgery, University College, London, UK.
5
Department of Neurology, Queen's Hospital, Romford, UK.
6
Department of Neurology, University of Cambridge, Cambridge, UK.
7
Department of Neurology, Barts and The London School of Medicine and Dentistry, London, UK.
8
Department of Neurology, Hurstwood Park Neurological Centre, Haywards Heath.
9
Department of Neurology, Department of Neurology, Barts and The London School of Medicine and Dentistry, London, UK.
10
Department of Neurology, University Hospital, Coventry, UK.
11
Department of Neurology, Kings' College Hospital, London, UK.
12
Department of Neurology, The Walton Hospital, Liverpool, UK.
13
Department of Neurology, University of Plymouth, Plymouth, UK.
PMID:
26101071
DOI:
10.1136/practneurol-2015-001139
No abstract available
Keywords:
MULTIPLE SCLEROSIS.
MeSH terms
Disease Management*
Drug Prescriptions / standards*
Guidelines as Topic / standards*
Humans
Multiple Sclerosis / therapy*
Physicians / standards*
United Kingdom